Kantify Nominated as Early Startup to Watch by Sifted

We are excited to share that Kantify has been nominated as an early startup to watch in Sifted's market report titled "AI-Driven Drug Discovery 2.0." This report, published by Sifted, the foremost media for the European startup community, highlights the most promising startups within the rapidly growing AI for drug discovery market.

In "AI-Driven Drug Discovery 2.0," Sifted examines the current state and future potential of the AI healthcare market. The report reveals compelling insights, such as the estimated value of the global AI healthcare market reaching $11 billion in 2021, with a projected value of $188 billion by 2030. This significant growth underscores the immense opportunities for innovation and disruption within the pharma and biotech sector.

Being nominated as an early startup to watch in this market report is a promising recognition of Kantify's pioneering work in AI-driven drug discovery. We are honored to be listed among the most promising startups shaping the future of healthcare innovation.

At Kantify, our vision is to transform drug discovery using AI. By leveraging advanced algorithms and data-driven insights, we aim to accelerate the development of life-saving treatments and improve patient outcomes.

Stay tuned as we progress on our journey to redefine the future of drug discovery, guided by the transformative potential of AI. Together, we can shape a world where cutting-edge technology and healthcare intersect to save lives and make a lasting impact.

Follow us for the latest updates and developments as we continue to make discoveries and progress in the AI for drug discovery market.